Cannabis-based Medicines Debate

Full Debate: Read Full Debate
Department: Home Office

Cannabis-based Medicines

David Duguid Excerpts
Tuesday 19th June 2018

(5 years, 10 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Sajid Javid Portrait Sajid Javid
- Hansard - - - Excerpts

First, Sativex was looked at for a particular condition. It is right that drugs are looked at the context of the condition that they are intended to help with. The hon. Gentleman makes a good wider point about whether, once the review is complete, we can get on with it, with any changes made quickly. That is exactly what I intend to do.

David Duguid Portrait David Duguid (Banff and Buchan) (Con)
- Hansard - -

As chairman of the all-party group on 22q11.2 deletion syndrome, I know many parents of children who have a rare genetic condition that often goes undiagnosed and, when diagnosed, is not always appropriately treated. From that experience, I am sure that Billy’s family welcome today’s statement. I welcome the fact that elements of the statement show that the Government look to the evidence and respond to the public interest, as well as that of the patient at the forefront.

Sajid Javid Portrait Sajid Javid
- Hansard - - - Excerpts

My hon. Friend is right. The process should absolutely be clinically led. We should listen to evidence from clinicians while drawing on international evidence, too. That is exactly what should feed into the outcome of the review.